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Prior to modern typing methods, cross-infection of P. aeruginosa between people with cystic fibrosis (CF) was felt to be rare.
Recently a number of studies have demonstrated the presence of clonal strains of P. aeruginosa infecting people with CF. The aim
of this study was to determine whether strains of P. aeruginosa demonstrated diﬀerences in resistance to desiccation and whether
preincubation in subminimum inhibitory concentrations (MICs) of β-lactam aﬀected desiccation resistance. The experimental
data were modelled to a first-order decay model and a Weibull decay model using least squares nonlinear regression. The Weibull
model was the preferred model for the desiccation survival. The presence of a mucoid phenotype promoted desiccation survival.
Preincubation with antibiotics did not have a consistent eﬀect on the strains of P. aeruginosa. Meropenem reduced desiccation
resistance, whereas ceftazidime had much less eﬀect on the strains studied.
1. Introduction
Pseudomonas aeruginosa is a gram-negative, nonfermenta-
tive, aerobic bacillus belonging to the family Pseudomon-
adaceae. The organism is ubiquitous within the environment
and is particularly isolated from moist areas such as water
and soil. P. aeruginosa causes chronic respiratory infections
in people with cystic fibrosis (CF) and acts as opportunistic
pathogen causing bacteraemia, urinary tract infections, and
hospital acquired pneumonia in patients with burns, urinary
catheters, and those on invasive ventilation [1]. Although P.
aeruginosa is a nonfermentative aerobe, it can grow under
anaerobic conditions using nitrate as an electron receptor. Its
ability to survive in a wide range of environmental conditions
is partially explained by its versatile nutritional abilities and
its ability to resist high concentrations of salt, dyes, dis-
infectants, and many common antibiotics. The bacteria has
been commonly found in the drains of wash basins in
hospital wards [2], and aerosols containing P. aeruginosa
can be detected when opening a tap [3, 4]. Isolation of P.
aeruginosa from tap water is due to contamination of the tap
itself, rather than the mains water supply [5].
Prior to the advent of modern genetic typing methods
cross-infection of P. aeruginosa between people with CF was
felt to be a rare event. More recently a number of studies have
been undertaken that demonstrate the presence of clonal
strains of P. aeruginosa infecting multiple patients in CF
clinics [6–9].
P. aeruginosa is intrinsically resistant to most commonly
used antibiotics. Antibiotic resistance is achieved through
a combination of restricted antibiotic uptake through the
outer membrane and a variety of energy-dependent mech-
anisms. The energy-dependent mechanisms through which
P. aeruginosa achieves antibiotic resistance include eﬄux
pumps and β lactamase-production. The energy-dependent
mechanisms are usually under close regulation, and antibi-
otic resistance is often a result of mutations in the regulatory
genes of these mechanisms [10]. Preincubation with antibi-
otics has been demonstrated to have a number of eﬀects
on P. aeruginosa including induction of a biofilm form of
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Table 1: Details of Pseudomonas aeruginosa strains.
Pseudomonas aeruginosa strain
MIC (μg mL−1)
Ceftazidime Meropenem
Environmental strain
NCIMB
10848
1.0 0.32
Unique CF 4412061 256 32
Unique CF mucoid 4390364-1 2.0 0.50
Manchester [7] 2003/492 256 32
Liverpool/Seacroft 4390416-2 8 32
Seacroft 4390195 256 32
Liverpool [18] 2003/493 2.0 3.0
Liverpool mucoid [18] 8 0.5
Leeds Paediatric [6] 4410030 256 32
Leeds Paediatric mucoid [6] 7175611-1 1.5 32
growth [11], improved heat and osmotic stress response
[12], changes to hydrophobicity [13], and reduced bacterial
adherence [14].
The aim of this study was to determine whether clonal
strains of P. aeruginosa, identified as part of routine clinical
sampling, demonstrated diﬀerences in resistance to desicca-
tion and whether preincubation in subminimum inhibitory
concentrations (MICs) of β-lactam antibiotics had an eﬀect
on the ability of the bacteria to resist desiccation. Both cef-
tazidime and meropenem are anti-pseudomonal antibiotics
that are commonly used in the care of people with CF.
2. Materials and Methods
2.1. Bacterial Strains. The environmental strain of P. aerug-
inosa (NCIMB 10848) was obtained from the National
Collection of Industrial and Marine Bacteria. Mucoid and
nonmucoid variants of the Liverpool strain [15] and a
nonmucoid variant of the Manchester strain [16] were
obtained from the Centre for Infectious Disease, University
of Edinburgh. All the other P. aeruginosa strains were
obtained from clinical samples of sputa from people with
CF and were genotyped by the Microbiology Department
of Leeds General Infirmary using Pulsed-Field Gel Elec-
trophoresis (PFGE) (See Table 1).
2.2. Antimicrobial Sensitivity Testing. MICs of ceftazidime
and meropenem were performed on Iso-Sensitest (ISA) agar
by Etest (AB Biodisk, Sweden) according to the manufac-
turer’s guidelines [17]. MICs were read after 24 h incubation
at 37◦C.
2.3. Desiccation Survival Assay
2.3.1. Preparation of Controlled Relative Humidity Chamber.
Controlled conditions of relative humidity were established
and maintained by the presence of saturated salt solution
in an air tight plastic box. 30 ± 3% relative humidity (RH)
was maintained by the presence of saturated solution of
CaCl2·6H2O (Sigma Chemicals, UK) [19, 20]. The tem-
perature of the room during the experiment was 22 ± 2◦C.
A digital thermohygrometer (Extech Instruments, USA) was
used to monitor relative humidity and temperature.
2.3.2. Inoculation of Glass Coverslips with Bacteria. After
determination of the viable cell concentration curve, strains
were grown to their maximum stationary phase cell con-
centration, and these cultures were used in the subsequent
experiments for determining the survival on a dry surface.
Strains were also grown for 24–48 h in nutrient broth or
nutrient broth containing 0.25 × MIC concentrations of
ceftazidime or meropenem at 37◦C in air, with shaking at
110 rpm.
A 1.0mL aliquot of the nutrient broth culture was
placed in a 1.5mL Eppendorf tube and centrifuged for five
minutes in a microcentrifuge (Eppendorf Centrifuge 5140)
at 13000 g. The supernatant fluid was discarded and the cell
pellet resuspended in 1.0mL of distilled water. 20 μL of the
cell suspensions was deposited onto the sterile coverslips, and
they were then placed in the controlled relative humidity
chamber.
2.3.3. Determination of Viable Count. Each glass coverslip
was placed in 2mL of sterile distilled water under aseptic
conditions using a sterile pair of forceps. Following appro-
priate serial dilutions using sterile distilled water the cell
suspension was inoculated onto Columbia blood agar plates
using the spread plate method. After overnight incubation
in air at 37◦C, the number of colony forming units was
counted using a colony counter. Three glass coverslips were
used separately for each count and three diﬀerent dilutions
were made for each coverslip. Viable counts were determined
at time 0 h, 1 h, 6 h, and 24 h.
2.4. Mathematical Models of Bacterial Inactivation
2.4.1. First-Order Decay Model. The first-order decay model
assumes that all the bacterial cells have an equal resistance to
lethal treatment. This results in a linear relationship between
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Table 2: Comparison of first order decay and Weibull survival models.
Model
Bacterial strain First order decay Weibull Preferred model P
k R2 δ p R2
Environmental 0.16 0.6599 0.15 0.30 0.9397 Weibull <0.0001
Liverpool 0.03 0.4678 0.003 0.18 0.6918 Weibull 0.0001
Liverpool mucoid 0.12 0.5336 0.003 0.15 0.9618 Weibull <0.0001
Manchester 0.10 0.8418 1.46 0.37 0.9478 Weibull <0.0001
Paediatric 0.19 0.6104 0.16 0.34 0.8550 Weibull <0.0001
Paediatric mucoid 0.14 0.5564 0.03 0.22 0.9635 Weibull <0.0001
Seacroft 0.02 0.8168 0.31 0.35 0.9836 Weibull <0.0001
Seacroft/Liverpool 0.14 0.7438 0.32 0.30 0.9107 Weibull <0.0001
Unique CF 0.15 0.9026 1.73 0.51 0.9746 Weibull <0.0001
Unique CF mucoid 0.10 0.8527 2.03 0.41 0.9402 Weibull <0.0001
the logarithm of the number of survivors and the treatment
time, as described in the following first-order decay kinetics
equation:
log(Nt) = log(No)− kt, (1)
where N0 = concentration at time 0, Nt = concentration at
time t, k = inactivation rate, and t = time.
2.4.2. Weibull Model. The Weibull model of bacterial decay
is a nonlinear model. It assumes that lethal events are
probabilities and that the corresponding survival curves
are cumulative forms of a distribution of lethal event, as
described in (2) [21]. The shape of the survival curve is
determined by p; when p < 1, the curve has a concave
upwards appearance, when p > 1, the curve has a concave
downwards appearance, and when p = 1, the survival
curve is linear. The value δ represents the time to the first
decimal reduction [22]. The scale and shape parameters are
not independent; therefore an error in δ will be balanced
by an error in p. Comparisons between survival curves
were undertaken by comparing the value for δ with a fixed
value for the shape parameter determined from the mean
of the initial values for p [22]. See the following Weibull
distribution equation [21]:
log(Nt) = log(N0)−
(
t
δ
)p
, (2)
where N0 = concentration at time 0, Nt = concentration
at time t, t = time, δ = scale parameter, and p = shape
parameter.
2.5. Statistical Analysis. The two models of bacterial decay
were modelled to the experimental data by least squares error
analysis using GraphPad Prism (GraphPad Inc, San Deigo,
USA). Comparisons between curves were made using the F-
Test. A P value of <0.05 was deemed significant.
Comparisons betweenWeibull survival curves weremade
with a fixed value for the shape parameter p determined by
the mean of the values p for the strains studied.
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Figure 1: Mean viable counts of diﬀerent strains of P. aeruginosa
within the desiccation survival model. Error bars represent standard
error of mean.
3. Results
Within the first hour following inoculation of all the diﬀerent
strains of P. aeruginosa onto a dry glass surface, there was
a rapid fall in viable counts of bacteria. All strains of
P. aeruginosa were still able to be recovered at 24 hours but
only at very low counts (Figure 1).
3.1. Comparison of Mathematical Survival Curves Models
in the Desiccation Model. The Weibull survival distribution
was the preferred model for all the strains of P. aeruginosa
examined in the desiccation survival assay (See Table 2).
When the Weibull distribution model was applied to the
experimental data all the strains of P. aeruginosa examined
had a concave survival curve with p < 1 (See Table 2). The
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average value for the scale parameter p was determined to be
0.313.
3.2. Influence of Mucoid Phenotype on Desiccation Survival.
The value of δ was greater for all the mucoid strains of
P. aeruginosa than the corresponding nonmucoid strain. This
diﬀerence reached statistical significance for the Unique CF
(P = 0.006) and Paediatric strains (P = 0.0476) (See
Figure 2).
3.3. Influence of Antibiotic Preincubation on Desiccation Sur-
vival on Time to First Decimal Reduction. Preincubation
with ceftazidime did not have any significant eﬀect on
any of the nonepidemic strains of P. aeruginosa. For epi-
demic strains it significantly increased the time to first
decimal reduction for the Paediatric nonmucoid strain and
the Seacroft/Liverpool strain (Paediatric non-mucoid P <
0.0001; Seacroft/Liverpool P = 0.0002) and significantly
reduced the time to first decimal reduction Liverpool mucoid
strain (P = 0.0143). The other epidemic strains were not
significantly aﬀected.
All nonepidemic strains had a significant reduction in
δ following preincubation with meropenem (Environmental
P = 0.0002; Unique CF P < 0.0001; Unique CF Mucoid
P < 0.0001). All epidemic strains of P. aeruginosa also had
a significant reduction in δ following preincubation with
meropenem, apart from the Paediatric, Seacroft, and Liver-
pool strains where the reduction in δ was not statistically
significant (Liverpool mucoid P < 0.0001; Manchester P <
0.0001; Paediatric mucoid P < 0.0001; Seacroft/Liverpool
P = 0.0007).
4. Discussion
There have been a number of studies demonstrating P. aerug-
inosa cross-infection between patients with cystic fibrosis
[6, 7, 9, 23, 24]. The method of cross-infection is not clear.
Dry surface contamination and aerosol dispersion have both
been postulated as potential routes of transmission [15, 25].
An important factor that contributes to the loss of viability
of bacteria both within aerosols and on dry surfaces is
desiccation.
The use of the Weibull model to compare the survival
curves of the diﬀerent strains of P. aeruginosa allows for
comparison of parameters of the survival curves and elim-
inates the impact of variations of the initial concentration of
bacteria that may influence the time innocula may survive.
We have demonstrated that the mucoid phenotype is
important for resistance to desiccation. All three strains
available as both mucoid and nonmucoid phenotypes
demonstrated greater resistance to desiccation when express-
ing the mucoid phenotype. This improved resistance to
desiccation may be due to the alginate coating reduc-
ing the rate of evaporation of water from the bacteria,
hence improving the ability of the organism to survive.
Panagea et al. demonstrated no diﬀerence in survival of
the Liverpool epidemic strain of P. aeruginosa regardless
of the expression of a mucoid or nonmucoid phenotype
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Figure 2: Values for δ determined from the Weibull distribution
using a fixed value for the scale parameter p with preincubation
with no antibiotic (δ), ceftazidime (δcef), and meropenem (δmero).
[15]. Comparing an alginate deficient mutant of PAO1
with wild type, Chang et al. demonstrated that alginate
production promoted desiccation resistance which would
support the findings presented in the current study [26].
Skaliy and Eagon demonstrated that the P. aeruginosa cells
in exponential phase of growth were most susceptible to the
eﬀects of desiccation compared to those in the stationary
phase and that the addition of extracellular slime did not
improve the desiccation resistance of exponential growth
bacterial cells [27]. This would suggest that the high rate
of metabolic activity associated with exponential growth
may be more important to desiccation resistance than the
presence of extracellular slime.
There was no pattern of improved desiccation resistance
between the epidemic strains and nonepidemic strains of
P. aeruginosa. All three groupings of strains according to the
value of δ contained both epidemic and nonepidemic strains
of P. aeruginosa. These data are contrary to the data presented
by Panagea et al [15]. They demonstrated that the Liverpool
epidemic strain demonstrated prolonged survival compared
to other strains. One explanation for the diﬀerences between
the previous and current study would be the lack of control
of relative humidity in the study of Panagea et al. [15].
A consistent eﬀect of preincubation withmeropenemwas
to reduce desiccation resistance in most of the strains stud-
ied. Carbapenems at sub-MIC levels have been demonstrated
to decrease outer membrane permeability, improve heat and
osmotic stress responses, and increase bacterial susceptibility
to neutrophil phagocytosis [12].
Ceftazidime had the lesser eﬀect on the strains studied,
causing a significant change in survival in only three of the
bacterial strains studied. While cephalosporins have been
shown to reduce bacterial adherence to pneumonocytes and
polymorphonuclear phagocytosis, they do not appear to
aﬀect the hydrophobicity of the bacterial surface [13, 14].
International Journal of Microbiology 5
Other β-lactam antibiotics have also been demonstrated
to modify the survival characteristics of P. aeruginosa.
Preincubation with piperacillin-tazobactam has been shown
to decrease adhesion, reduce motility, reduce twitching,
reduce biofilm formation, and increase the sensitivity to
oxidative stress [28].
This study demonstrated that P. aeruginosa can survive
within a dry environment for prolonged periods of time
and that the mucoid phenotype is an important factor
promoting survival. It also demonstrates that preincubation
with sub-MIC levels may have important eﬀects on the
physiology of the bacteria in relation to their resistance to
desiccation. Promoting bacterial survival through antibiotic
exposure could have important clinical consequences by
potentiating the risk of cross infection between people with
CF. Further studies should be undertaken looking at the role
sub-MIC concentrations of diﬀerent antibiotics may have
in promoting or inhibiting cross-infection with epidemic
strains of P. aeruginosa in CF units.
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